Your browser doesn't support javascript.
Cigarette Smoking and Risk Perceptions During the COVID-19 Pandemic Reported by Recently Hospitalized Participants in a Smoking Cessation Trial.
Rigotti, Nancy A; Chang, Yuchiao; Regan, Susan; Lee, Scott; Kelley, Jennifer H K; Davis, Esa; Levy, Douglas E; Singer, Daniel E; Tindle, Hilary A.
  • Rigotti NA; Tobacco Research and Treatment Center, Division of General Internal Medicine, and Mongan Institute, Department of Medicine, Massachusetts General Hospital, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA. nrigotti@partners.org.
  • Chang Y; Harvard Medical School, Boston, MA, USA. nrigotti@partners.org.
  • Regan S; Tobacco Research and Treatment Center, Division of General Internal Medicine, and Mongan Institute, Department of Medicine, Massachusetts General Hospital, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
  • Lee S; Harvard Medical School, Boston, MA, USA.
  • Kelley JHK; Tobacco Research and Treatment Center, Division of General Internal Medicine, and Mongan Institute, Department of Medicine, Massachusetts General Hospital, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
  • Davis E; Harvard Medical School, Boston, MA, USA.
  • Levy DE; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Singer DE; Institute for Global Health, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Tindle HA; Tobacco Research and Treatment Center, Division of General Internal Medicine, and Mongan Institute, Department of Medicine, Massachusetts General Hospital, 100 Cambridge Street, Suite 1600, Boston, MA, 02114, USA.
J Gen Intern Med ; 36(12): 3786-3793, 2021 12.
Article in English | MEDLINE | ID: covidwho-1260606
ABSTRACT

BACKGROUND:

Cigarette smoking is a risk factor for severe COVID-19 disease. Understanding smokers' responses to the pandemic will help assess its public health impact and inform future public health and provider messages to smokers.

OBJECTIVE:

To assess risk perceptions and change in tobacco use among current and former smokers during the COVID-19 pandemic.

DESIGN:

Cross-sectional survey conducted in May-July 2020 (55% response rate)

PARTICIPANTS:

694 current and former daily smokers (mean age 53, 40% male, 78% white) who had been hospitalized pre-COVID-19 and enrolled into a smoking cessation clinical trial at hospitals in Massachusetts, Pennsylvania, and Tennessee. MAIN

MEASURES:

Perceived risk of COVID-19 due to tobacco use; changes in tobacco consumption and interest in quitting tobacco use; self-reported quitting and relapse since January 2020. KEY

RESULTS:

68% (95% CI, 65-72%) of respondents believed that smoking increases the risk of contracting COVID-19 or having a more severe case. In adjusted analyses, perceived risk was higher in Massachusetts where COVID-19 had already surged than in Pennsylvania and Tennessee which were pre-surge during survey administration (AOR 1.56, 95% CI, 1.07-2.28). Higher perceived COVID-19 risk was associated with increased interest in quitting smoking (AOR 1.72, 95% CI 1.01-2.92). During the pandemic, 32% (95% CI, 27-37%) of smokers increased, 37% (95% CI, 33-42%) decreased, and 31% (95% CI, 26-35%) did not change their cigarette consumption. Increased smoking was associated with higher perceived stress (AOR 1.49, 95% CI 1.16-1.91). Overall, 11% (95% CI, 8-14%) of respondents who smoked in January 2020 (pre-COVID-19) had quit smoking at survey (mean, 6 months later) while 28% (95% CI, 22-34%) of former smokers relapsed. Higher perceived COVID-19 risk was associated with higher odds of quitting and lower odds of relapse.

CONCLUSIONS:

Most smokers believed that smoking increased COVID-19 risk. Smokers' responses to the pandemic varied, with increased smoking related to stress and increased quitting associated with perceived COVID-19 vulnerability.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Smoking Cessation / Cigarette Smoking / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male / Middle aged Language: English Journal: J Gen Intern Med Journal subject: Internal Medicine Year: 2021 Document Type: Article Affiliation country: S11606-021-06913-3

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Smoking Cessation / Cigarette Smoking / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Female / Humans / Male / Middle aged Language: English Journal: J Gen Intern Med Journal subject: Internal Medicine Year: 2021 Document Type: Article Affiliation country: S11606-021-06913-3